Biologic drugs during COVID-19 outbreak
- 1 October 2020
- journal article
- letter
- Published by Wiley in International Journal of Dermatology
- Vol. 59 (10) , 1293
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Complicated coronavirus disease 2019 (COVID‐19) in a psoriatic patient treated with ixekizumabInternational Journal of Dermatology, 2020
- Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in Sardinia (Italy)Journal of the European Academy of Dermatology and Venereology, 2020
- Dermatologists and SARS‐CoV‐2: the impact of the pandemic on daily practiceJournal of the European Academy of Dermatology and Venereology, 2020
- The impact of the COVID ‐19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experienceBritish Journal of Dermatology, 2020
- A survey of psoriasis patients on biologics during COVID-19: a single centre experienceJournal of Dermatological Treatment, 2020
- Should biologics for psoriasis be interrupted in the era of COVID-19?Journal of the American Academy of Dermatology, 2020